Company Search:
Advanced Search
Sponsored Links
Imugene Limited Company Snapshot
Imugene Limited operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imugene Limited with three other companies in this sector in AUSTRALIA : Medlab Clinical Ltd (2020 sales of 5.37 million Australian Dollars [US$4.14 million] of which 67% was Pharmaceutical Research), Paradigm Biopharmaceuticals Ltd (4.70 million Australian Dollars [US$3.62 million] ), and Invion Limited (3.48 million Australian Dollars [US$2.68 million] of which 100% was Drug Development).

Sales Analysis. Sales were up sharply during the second fiscal quarter of 2021 versus the previous year's second quarter. During the second fiscal quarter of 2021, sales at Imugene Limited totalled A$4.11 million. This is an increase of 73.1% from the A$2.37 million in sales at the company during the second quarter of 2020. Imugene Limited reported sales of A$4.21 million (US$3.25 million) for the fiscal year ending June of 2020. This represents a decrease of 7.3% versus 2019, when the company's sales were A$4.54 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Imugene Limited
  Stock Performance Chart for Imugene Limited
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): .35
(Figures in Australian Dollars)
1 Week -11.5%   13 Weeks 11.3%  
4 Weeks 213.6%   52 Weeks 858.3%  
Imugene Limited Key Data:
  Ticker: IMU Country: Australia
  Exchanges: BLN ASX Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 4,209,703
(Year Ending Jan 2021).
  Currency: Australian Dollars Market Cap: 1,635,617,443
  Fiscal Yr Ends: June Shares Outstanding: 4,740,920,126
  Share Type: Ordinary Closely Held Shares: 872,968,439
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.